Syneron Medical Ltd. (CIK: 0001291361) EDGAR, Information, Filings... CompaniesBIO.Com

Syneron Medical Ltd.

Mailing address
INDUSTRIAL ZONE, P.O.B. 550, YOKNEAM ILLIT, L3, 20692
Phone
972-4-909-6200
State location
N/A
State of incorporation
N/A
Fiscal year end
N/A
SIC
3845 - (CF Office: Office of Life Sciences) ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Filings
N/A

Owner	Filings	Transaction Date	Type of Owner
NORTH TIDE CAPITAL, LLC	0001557543	Mar-21-2016	10 percent owner
Laughlin Conan	0001594068	Mar-21-2016	10 percent owner
North Tide Capital Master, LP	0001594882	Mar-21-2016	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Syneron Medical Ltd.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001178913-17-002203 (34 Act) Size: KB	Aug-01-2017	005-80182 17995294
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001178913-17-002143 (34 Act) Size: KB	Jul-27-2017	000-50867 17984683
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001178913-17-002067 (33 Act) Size: KB	Jul-17-2017	333-192729 17966937
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001178913-17-002065 (33 Act) Size: KB	Jul-17-2017	333-164351 17966928
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001178913-17-002064 (33 Act) Size: KB	Jul-17-2017	333-164250 17966926
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001178913-17-002062 (33 Act) Size: KB	Jul-17-2017	333-213539 17966919
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001178913-17-002060 (33 Act) Size: KB	Jul-17-2017	333-120559 17966914
25-NSE	Document	Acc-no: 0001354457-17-000132 (34 Act) Size: KB	Jul-17-2017	000-50867 17966709
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001178913-17-002055 (34 Act) Size: KB	Jul-17-2017	001-34559 17966635
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001144204-17-036026 (34 Act) Size: KB	Jul-07-2017	005-80182 17954438
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001178913-17-001829 (34 Act) Size: KB	Jun-15-2017	001-34559 17913210
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000929638-17-000511 (34 Act) Size: KB	May-30-2017	005-80182 17877420
SD	Document	Acc-no: 0001178913-17-001570 (34 Act) Size: KB	May-23-2017	001-34559 17862720
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001178913-17-001535 (34 Act) Size: KB	May-18-2017	001-34559 17853807
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001178913-17-001475 (34 Act) Size: KB	May-15-2017	001-34559 17844240
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001157523-17-001535 (34 Act) Size: KB	May-11-2017	005-80182 17832539
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001178913-17-001359 (34 Act) Size: KB	May-10-2017	001-34559 17828419
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001157523-17-001514 (34 Act) Size: KB	May-10-2017	005-80182 17828356
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001178913-17-001256 (34 Act) Size: KB	May-01-2017	001-34559 17801281
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000902664-17-002011 (34 Act) Size: KB	Apr-19-2017	005-80182 17769080

Recent 20 filings. View all Syneron Medical Ltd. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Syneron Medical Ltd. overview
Syneron Medical Ltd. job
Syneron Medical Ltd. stock
Syneron Medical Ltd. ownership
Syneron Medical Ltd. CEO
Syneron Medical Ltd. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.